Wu Deyan, Zheng Xuehua, Liu Runduo, Li Zhe, Jiang Zan, Zhou Qian, Huang Yue, Wu Xu-Nian, Zhang Chen, Huang Yi-You, Luo Hai-Bin
School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Acta Pharm Sin B. 2022 Mar;12(3):1351-1362. doi: 10.1016/j.apsb.2021.09.027. Epub 2021 Sep 30.
Scaffold hopping refers to computer-aided screening for active compounds with different structures against the same receptor to enrich privileged scaffolds, which is a topic of high interest in organic and medicinal chemistry. However, most approaches cannot efficiently predict the potency level of candidates after scaffold hopping. Herein, we identified potent PDE5 inhibitors with a novel scaffold a free energy perturbation (FEP)-guided scaffold-hopping strategy, and FEP shows great advantages to precisely predict the theoretical binding potencies Δ between ligands and their target, which were more consistent with the experimental binding potencies Δ (the mean absolute deviations < 2 kcal/mol) than those Δ or Δ predicted by the MM-PBSA or MM-GBSA method. Lead had an IC of 8.7 nmol/L and exhibited a different binding pattern in its crystal structure with PDE5 from the famous starting drug tadalafil. Our work provides the first report the FEP-guided scaffold hopping strategy for potent inhibitor discovery with a novel scaffold, implying that it will have a variety of future applications in rational molecular design and drug discovery.
骨架跃迁是指针对同一受体对具有不同结构的活性化合物进行计算机辅助筛选,以富集优势骨架,这是有机化学和药物化学中备受关注的一个话题。然而,大多数方法在骨架跃迁后无法有效预测候选物的活性水平。在此,我们通过一种自由能扰动(FEP)引导的骨架跃迁策略鉴定出了具有新型骨架的强效磷酸二酯酶5(PDE5)抑制剂,并且FEP在精确预测配体与其靶点之间的理论结合亲和力Δ方面显示出巨大优势,与通过MM - PBSA或MM - GBSA方法预测的Δ或Δ相比,其与实验结合亲和力Δ更为一致(平均绝对偏差<2 kcal/mol)。先导化合物的IC为8.7 nmol/L,并且在其与PDE5的晶体结构中呈现出与著名起始药物他达拉非不同的结合模式。我们的工作首次报道了用于发现具有新型骨架的强效抑制剂的FEP引导的骨架跃迁策略,这意味着它在合理的分子设计和药物发现中将有多种未来应用。